Natco – pharmaceutical daily

January 6, 2017 Off

India’s Natco cleared to sell generic version of Teva’s leukemia treatment Trenda in USA

Indian drugmaker Natco Pharma has gotten the approval from the U.S. regulator for generic version of Teva’s leukemia treatment Trenda (Bendamustine Hydrochloride powder for Injection).

January 21, 2016 Off

Indian Natco to sell Bristol-Myer Squibb’s hepatitis C medicine in 112 countries

By Dino Mustafić

Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…

December 14, 2015 Off

Alvogen to market Natco’s generic Tamiflu capsules until 2017

By Dino Mustafić

Alvogen to market Natco’s generic Tamiflu capsules until 2017.